James D. Clark - Jan 28, 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
SVP, Cont & Chief Acct Officer
Signature
/s/ James D. Clark
Stock symbol
CVS
Transactions as of
Jan 28, 2022
Transactions value $
-$40,838
Form type
4
Date filed
2/1/2022, 03:43 PM
Previous filing
Oct 14, 2022
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Options Exercise $620K +6.06K +34.63% $102.26 23.6K Jan 28, 2022 Direct
transaction CVS Common Stock Sale -$660K -6.06K -25.72% $109.00 17.5K Jan 28, 2022 Direct F1
holding CVS Common Stock (restricted) 16.9K Jan 28, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -6.06K -100% $0.00* 0 Jan 28, 2022 Common Stock 6.06K $102.26 Direct F2
holding CVS Stock Option 24.2K Jan 28, 2022 Common Stock 24.2K $54.19 Direct F3
holding CVS Stock Option 7.51K Jan 28, 2022 Common Stock 7.51K $62.21 Direct F4
holding CVS Stock Option 9.05K Jan 28, 2022 Common Stock 9.05K $78.05 Direct F5
holding CVS Stock Option 7.04K Jan 28, 2022 Common Stock 7.04K $104.82 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Options became exercisable in four equal annual installments beginning on 4/1/2016.
F3 Options became exercisable in four equal annual installments, commencing 4/1/2020.
F4 Options became exercisable in four equal annual installments, commencing 4/1/2019.
F5 Options became exercisable in four equal annual installments beginning on 4/3/2018.
F6 Options became exercisable in four equal annual installments beginning on 4/1/2017.